variant,gene_symbol,summary,clinical_importance,evidence,impact,frequency,category,inheritance,zygosity,PMIDs,dbSNP_ID,penetrance_score,build_37_chromosome,build_37_position,build_37_variant_allele,getev_report_url
APOE-C130R,APOE,"This is generally known as the ApoE4 allele of ApoE and is associated with increased risk of Alzheimer's. 20-25% of individuals are heterozygous for this variant, and 1-2% are homozygous. Data from Khachaturian et al. suggests an average 7% of all individuals developed Alzheimer's by the age of 80; when this is split by ApoE4 status: 10% of ApoE4 heterozygotes (3% increased attributable risk), 40% of ApoE4 homozygotes (33% increased attributable risk), and 5% of non-carriers (2% decreased attributable risk). Notably, their model suggests 70-75% of people would eventually develop Alzheimer's by the age of 100 regardless of ApoE4 genotype (and 25-30% are resistant, regardless of genotype), but that ApoE4 variants shift the disease onset to occur significantly earlier (4 years earlier for heterozygous carriers, 13 years for homozygotes).",High,Well-established,Pathogenic,0.14,Mental and behavioral;Nervous system,Complex/Other,Heterozygous,9343467;11950276;15123497;17428983,rs429358,4,chr19,45411941,C,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
NCF1-Y26Shift,NCF1,"Causes chronic granulomatous disease in a recessive manner. Recorded in ClinVar by OMIM and GeneReviews (www.ncbi.nlm.nih.gov/clinvar/RCV000002337/). Several publications support this variant as causal, including Noack et al 2001 (PMID: 11133775) which reports that 97% of patients with the A47(0) subtype of this disease carry this variant.",High,Well-established,Pathogenic,,Other,Recessive,Heterozygous,,,5,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
ALPL-E298K,ALPL,Proposed to cause infantile hypophosphatasia in a recessive manner. This comes from a case study reported by Orimo et al 1994 (PMID: 7833929) and is recorded in ClinVar by OMIM (http://www.ncbi.nlm.nih.gov/clinvar/RCV000014657/).,High,Uncertain,Pathogenic,,Other,Recessive,Heterozygous,7833929,,5,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
RYR2-G1886S,RYR2,"Reported to cause arrhythmogenic right ventricular cardiomyopathy when compound heterozygous with G1885E, although this finding is weakened after correcting for multiple hypotheses and it is unclear what penetrance such a genotype might have, if it is causal.",High,Uncertain,Pathogenic,0.061,"Heart and circulatory;Muscular, skeletal, and connective tissue;Nervous system",Recessive,Heterozygous,16769042;18326664,rs3766871,4,chr1,237778084,A,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
COL4A1-Q1334H,COL4A1,"This common variant has been associated with arterial stiffness and, in Japanese, a small increased risk of myocardial infarction (MI, a.k.a. heart attack). This last observation supported a dominant effect for this variant and, assuming a lifetime risk of 15% for MI, we estimate carriers have an additional risk of 0.5-3%.",Low,Likely,Pathogenic,0.32,Heart and circulatory,Dominant,Heterozygous,10334796;18077766;20031579,rs3742207,2,chr13,110818598,G,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
RPGRIP1L-A229T,RPGRIP1L,"This variant is generally not considered pathogenic, but when combined with other severe variants it is associated with rare genetic diseases which involve retinal degeneration. Carrying this variant increases the risk of these diseases, but the overall increased risk is very small because the diseases are very rare.",Low,Likely,Pathogenic,0.056,Hearing and vision,Unknown,Heterozygous,19430481,rs61747071,0,chr16,53720436,T,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
rs5186,,"This common noncoding genetic variant has an allele frequency of ~30% and is associated with an increased risk of hypertension. If ~25% of non-carriers have hypertension, Bonnardeaux et al's data predict ~4% increased risk of hypertension per copy of this variant. This SNP is in the 3' noncoding region of the AGTR1 transcript (angiotensin II type 1 receptor), also known as AT2R1 or AT1R, which is a target of hypertension drugs.",Low,Likely,Pathogenic,0.21,Drug response;Heart and circulatory,Unknown,Heterozygous,"8021009;
11250978;11593098;16046653;16675453;17668390",rs5186,2,chr3,148459988,C,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
H6PD-R453Q,H6PD,"This common variant may have a small pathogenic effect by contributing to cortisone reductase deficiency (a rare abnormality) when homozygous and combined with a serious pathogenic variant. The same authors have tested and ruled out a contribution to polycystic ovary syndrome (similar phenotype, more common disease).",Low,Uncertain,Pathogenic,0.31,Genital and urinary;Metabolism,Recessive,Homozygous,12858176;15827106;16817821,rs6688832,1,chr1,9323910,A,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
WFS1-R611H,WFS1,"This nonsynonymous SNP is associated with Wolfram Syndrome (known as DIDMOAD), which is characterized by early-onset non-autoimmune diabetes mellitus, diabetes insipidus, optic atrophy, and deafness) and to adult Type Two Diabetes Mellitus.  The WFS1 gene maps to chromosome 4p16.3.  The variant has been shown to be statistically associated with type II diabetes in six UK studies and one study of Ashkenazi Jews (Sandhu, M., et al., Minton et al.).",Low,Uncertain,Not Reviewed,0.4,Hearing and vision;Immune system;Metabolism,Recessive,Homozygous,17603484;17719176;23257691,rs734312,1,chr4,6303354,A,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
TLR5-R392X,TLR5,"This variant is believed to impair the ability to generate an immune response to the flagella of the bacteria. It is weakly associated with an increased incidence of Legionnaires' Disease, p = 0.085, increased lifetime risk of disease ~0.88% (about twice average). The variant is also weakly associated with a reduced incidence of systemic lupus erythematosus, p = 0.165.",Low,Uncertain,Pathogenic,0.044,Immune system,Complex/Other,Heterozygous,14623910;16027372;17516623;18230059,rs5744168,1,chr1,223285200,A,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
POLG-Q1236H,POLG,"Generally a nonpathogenic polymorphism, but may have a modifier effect that increases severity when combined in cis with other pathogenic variants.",Low,Uncertain,Pathogenic,0.058,Other,Complex/Other,Heterozygous,15917273;16595552,rs3087374,0,chr15,89859994,A,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
SP110-L425S,SP110,"This variant is associated with a slightly increased risk of tuberculosis. It is unclear whether it is itself causal, or in linkage disequilibrium with some other causal variant that has a stronger effect.",Low,Uncertain,Pathogenic,0.86,Immune system,Unknown,Homozygous,16803959,rs3948464,1,chr2,231050715,G,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
TP53-P72R,TP53,"This is a common variant was first reported as a polymorphism. It has since had mixed associations with cancer: Storey et al. conclude a 7x *increased* risk of HPV cancer for homozygotes vs hets, but Jones et al. find a 1.98x *decreased* risk for colorectal cancer. This variant may have significant impact on particular cancers, but it is unclear what effect it has on the overall burden of cancer.",Low,Uncertain,Pathogenic,0.63,Cancer,Unknown,Heterozygous,1975675;9607760;15355915;19837266;20615891;22184967,rs1042522,0,chr17,7579472,C,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
rs1544410,,"rs1544410 is a Vitamin D Receptor (VDR) single nucleotide polymorphism. It is unlikely that it has functional significance because it is located in an intron (Liu et. al.), but it is in strong linkage disequilibrium with rs731236 (Dvornyk et al), which is located in an exon. ",Low,Uncertain,Pharmacogenetic,0.35,Other,Unknown,Heterozygous,,rs1544410,0,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
FUT2-W154X,FUT2,"This recessive protective variant confers resistance to norovirus (which causes stomach flu). 20% of Caucasians and Africans are homozygous for this variant and are ""non-secretors"": they do not express ABO blood type antigens in their saliva or mucosal surfaces. Most strains of norovirus bind to these antigens in the gut, and so this non-secretor status confers almost total resistantance to most types of norovirus. There are notable exceptions, some strains of norovirus bind a different target and are equally infectious for secretors and non-secretors.",Moderate,Well-established,Protective,0.49,Blood;Immune system,Recessive,Heterozygous,7876235;12692541;19625485;20031047;22025362,rs601338,5,chr19,49206674,A,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
CFB-R32Q,CFB,"This variant is associated with a significant protective effect -- individuals with this variant are about half as likely to have age-related macular degeneration. Appears to be an additive effect, with homozygotes having a stronger protective effect.",Moderate,Likely,Protective,0.12,Hearing and vision,Dominant,Homozygous,16518403;16936732;19117936,rs641153,3,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
PRNP-M129V,PRNP,"This variant is associated with some protective effects for prion disease -- individuals homozygous for this variant are less susceptible to Creutzfeldt-Jakob, and Papua New Guinea individuals heterozygotes at this site are less susceptible to kuru.

",Low,Well-established,Protective,0.34,Other,Complex/Other,Heterozygous,18236005;19081515,rs1799990,0,chr20,4680251,G,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
CFH-V62I,CFH,"Associated with a decreased risk for age related macular degeneration (ARMD). Homozygotes for this have a 4-5% decreased attributable risk (3-4% vs. average 8% risk), heterozygotes have slightly lower than average risk (7%). Non-carriers have an increased risk (12-13%). ARMD impairs sharp vision as age progresses. While there is no cure, treatment can slow progression of the disease and environmental factors (smoking and obesity) contribute to higher risk.",Low,Likely,Protective,0.39,Hearing and vision;Metabolism,Complex/Other,Heterozygous,15870199,rs800292,2,chr1,196642233,A,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
NPC1-H215R,NPC1,"This variant is associated with a reduced risk of obesity, with an additive effect of -0.084 BMI per allele (an average of 0.54 pounds less, per allele, in a 5'6"" individual).





",Low,Likely,Protective,0.3,Metabolism,Complex/Other,Heterozygous,19151714;19174833;19910939,rs1805081,2,chr18,21140432,C,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
PTCH1-T728M,PTCH1,"Reported to cause holoprosencephaly, which causes facial and brain malformations. Submitted to ClinVar by OMIM (http://www.ncbi.nlm.nih.gov/clinvar/RCV000008705/), based on Ming et al 2002 (PMID: 11941477) and Rahimov et al 2006 (PMID: 17096318). Proposed inheritance pattern unclear â€“ possibly dominant with variable penetrance. However, this pathogenic effect is strongly contradicted by ExAC allele frequency data which reports the variant has an allele frequency of 2.2% in African ancestry.",Low,Well-established,Benign,0.0077,Nervous system,Unknown,Heterozygous,,,,chr9,98231100,A,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
TGM1-V518M,TGM1,"Probably a non-pathogenic polymorphism. It was initially thought to be involved in autosomal recessive congenital ichthyosis, but later authors found the variant in numerous healthy controls.",Low,Likely,Benign,0.011,Skin,Unknown,Heterozygous,19241467,rs35312232,,chr14,24724663,T,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
NOTCH3-A1020P,NOTCH3,"Probably nonpathogenic. Reported by Scheid et al. as possibly causing CADASIL in a dominant manner, but an immediate follow-up from Quattrone et al. disagreed with this hypothesis, pointing to the presence of the variant in their own controls and the high allele frequency for the variant seen in dbSNP data.",Low,Likely,Benign,0.11,Nervous system,Unknown,Heterozygous,18765654;19528524;22348356,rs35769976,,chr19,15291576,G,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
NEFL-S472Shift,NEFL,"Although a frameshift in this gene would be predicted to cause Charcot-Marie Neuropathy, this particular position appears to reflect a single base insertion error/mutation in the reference genome (in other words, normal individuals are always homozygous for a deletion at this position relative to reference). See chr8:24,811,060-24,811,080 annotations on UCSC.",Low,Likely,Benign,,Nervous system,Unknown,Homozygous,,rs11340767,,,,,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
GAA-E689K,GAA,This is also known as the GAA*4 allozyme is frequent in the Asian population and appears to have somewhat reduced enzyme activity. Kroos et al. rule out pathogenic effect.,Low,Uncertain,Benign,0.03,Other,Complex/Other,Heterozygous,18301443,rs1800309,,chr17,78087041,A,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
TAS2R38-I296V,TAS2R38,"This variant is associated with ""taster"" status of PTC, along with 49P and 262A. Due to linkage disequilibrium, the independent effects of positions 296 and 262 is unclear. The presence of 49P confers taster status in a dominant fashion, but in the absence of 49P, the presence of 262A/296V is still positively associated with tasting PTC.",Low,Uncertain,Benign,0.46,Other,Unknown,Heterozygous,12595690;20675712,rs10246939,,chr7,141672604,C,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
DSPP-R68W,DSPP,"Probably benign. One report linked this to causing dentinogenesis Imperfecta type II in a large Swedish family, but subsequent publications have observed this is a common variant and conclude it is a nonpathogenic polymorphism.",Low,Uncertain,Benign,0.14,"Mouth, liver, and digestive",Unknown,Homozygous,14758537;17452557;18797159,rs36094464,,chr4,88533540,T,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
PCSK9-G670E,PCSK9,This variant is likely benign. ,Low,Uncertain,Benign,0.89,Other,Unknown,Homozygous,19351729,rs505151,,chr1,55529187,A,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
APOB-Y1422C,APOB,This position is almost certainly an error in the HG18 reference sequence. ,Low,Uncertain,Benign,1.0,Other,Unknown,Homozygous,,rs568413,,chr2,21235475,C,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
TAS2R38-A49P,TAS2R38,"This variant is strongly associated with causing the ""taster"" phenotype of phenylthiocarbamine (PTC) in a dominant manner.",Low,Uncertain,Benign,0.43,Other,Unknown,Heterozygous,12595690;15883422;20675712,rs713598,,chr7,141673345,G,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
USH1C-V130I,USH1C,"This moderately common variant (1000 genomes allele frequency of 6.2%) was reported found heterozygously in a patient with Usher syndrome. However, the high allele frequency and fact that it is a conservative amino acid change supports classifying this variant as benign.",Low,Uncertain,Benign,0.017,Hearing and vision,Unknown,Heterozygous,12702164,rs55843567,,chr11,17548878,T,http://evidence.pgp-hms.org/genomes?display_genome_id=592d0f81389b4e8c864b7235c525fb2e9aad907d
